Insider · CIK 0001452635

Babu Yarlagadda S

Reports to the SEC for 1 company · BIRMINGHAM, AL

sec.gov

Transactions

Companies

Filings

CIK

0001452635

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-11-14	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+50K sh	$1.42	+$71K	330,056
2022-11-14	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+50K sh	$1.42	+$71K	280,056
2022-11-14	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Discovery Officer	SSale	−31.5K sh	$13.88	−$437K	298,541
2022-11-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−50K sh	—	—	0
2022-11-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−50K sh	—	—	0
2022-03-07	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Discovery Officer	SSale	−20K sh	$17.16	−$343K	230,056
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+164K sh	—	—	164,000
2021-12-14	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Chief Discovery Officer	AAward	+35K sh	—	—	250,056
2021-12-07	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+62K sh	$4.73	+$293K	245,156
2021-12-07	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−62K sh	—	—	0
2021-12-07	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Discovery Officer	SSale	−30.1K sh	$12.20	−$367K	215,056
2021-02-19	BCRXBIOCRYST PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−50K sh	—	—	0
2021-02-19	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+50K sh	$4.15	+$208K	205,587
2021-02-19	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−22.4K sh	$11.53	−$259K	183,156
2020-12-15	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+280K sh	—	—	280,000
2020-12-03	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+17K sh	—	—	17,000
2020-02-21	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+18K sh	—	—	18,000
2020-02-14	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+31.5K sh	—	—	31,500
2019-12-17	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+225K sh	—	—	225,000
2019-11-18	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	Chief Discovery Officer	PPurchase	+25K sh	$1.45	+$36.3K	155,587
2019-01-31	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−7,702 sh	$8.68	−$66.9K	120,084
2019-01-31	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−1,685 sh	$8.68	−$14.6K	130,587
2019-01-31	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−19.7K sh	—	—	0
2019-01-31	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−12.2K sh	—	—	0
2019-01-31	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+19.7K sh	$1.20	+$23.6K	127,786
2019-01-31	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+12.2K sh	$1.20	+$14.6K	132,272
2019-01-01	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−771 sh	$8.07	−$6,221.97	108,100
2018-12-20	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+235K sh	—	—	235,000
2018-03-06	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−9,378 sh	—	—	0
2018-03-06	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−20.6K sh	—	—	0
2018-03-06	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+9,378 sh	$3.26	+$30.6K	114,773
2018-03-06	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−15.2K sh	$5.18	−$78.9K	105,395
2018-03-06	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+20.6K sh	$3.26	+$67.2K	120,618
2018-03-06	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−5,902 sh	$5.18	−$30.6K	108,871
2018-01-20	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−3,872 sh	$5.59	−$21.6K	99,996
2018-01-01	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−838 sh	$4.91	−$4,114.58	103,868
2017-12-20	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+100K sh	—	—	100,000
2017-08-31	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+27K sh	—	—	27,000
2017-02-27	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+175K sh	—	—	175,000
2017-01-20	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−5,083 sh	$5.95	−$30.2K	104,706
2017-01-01	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−1,639 sh	$6.33	−$10.4K	109,789
2016-08-25	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Discovery Officer	SSale	−30K sh	$4.06	−$122K	111,428
2016-05-23	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+129K sh	—	—	129,427
2016-03-01	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−906 sh	$2.13	−$1,929.78	141,428
2016-01-20	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−4,724 sh	$7.55	−$35.7K	142,334
2016-01-01	BCRXBIOCRYST PHARMACEUTICALS INCF Tax Payment	Chief Discovery Officer	FTax Payment	−1,639 sh	$10.32	−$16.9K	147,058
2015-12-29	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+62.6K sh	—	—	62,573
2015-05-13	BCRXBIOCRYST PHARMACEUTICALS INC · Emp. Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+17K sh	—	—	17,000
2015-03-19	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Discovery Officer	SSale	−12.1K sh	$10.16	−$123K	148,697
2015-03-05	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Chief Discovery Officer	SSale	−37.4K sh	$10.59	−$396K	160,802

Recent filings

Accepted (ET)
Nov 164
Babu Yarlagadda S0001127602-22-025761
SEC(opens sec.gov)
Mar 94
Babu Yarlagadda S0001127602-22-008780
SEC(opens sec.gov)
Dec 164
Babu Yarlagadda S0001127602-21-031134
SEC(opens sec.gov)
Dec 94
Babu Yarlagadda S0001127602-21-030610
SEC(opens sec.gov)
Feb 234
Babu Yarlagadda S0001127602-21-007295
SEC(opens sec.gov)
Dec 174
Babu Yarlagadda S0001127602-20-031788
SEC(opens sec.gov)
Dec 74
Babu Yarlagadda S0001127602-20-030696
SEC(opens sec.gov)
Feb 254
Babu Yarlagadda S0001127602-20-007672
SEC(opens sec.gov)
Feb 194
Babu Yarlagadda S0001127602-20-006501
SEC(opens sec.gov)
Dec 194
Babu Yarlagadda S0001127602-19-035551
SEC(opens sec.gov)
Nov 184
Babu Yarlagadda S0001127602-19-033004
SEC(opens sec.gov)

Companies

BIOCRYST PHARMACEUTICALS INCChief Discovery OfficerBCRX

Address

2190 PARKWAY LAKE DR

BIRMINGHAM, AL, 35244